BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26268945)

  • 1. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.
    Osuala KO; Sameni M; Shah S; Aggarwal N; Simonait ML; Franco OE; Hong Y; Hayward SW; Behbod F; Mattingly RR; Sloane BF
    BMC Cancer; 2015 Aug; 15():584. PubMed ID: 26268945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ.
    Sameni M; Cavallo-Medved D; Franco OE; Chalasani A; Ji K; Aggarwal N; Anbalagan A; Chen X; Mattingly RR; Hayward SW; Sloane BF
    Breast Cancer Res; 2017 May; 19(1):56. PubMed ID: 28506312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.
    Erez N; Glanz S; Raz Y; Avivi C; Barshack I
    Biochem Biophys Res Commun; 2013 Aug; 437(3):397-402. PubMed ID: 23831470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
    Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
    J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.
    Jedeszko C; Victor BC; Podgorski I; Sloane BF
    Cancer Res; 2009 Dec; 69(23):9148-55. PubMed ID: 19920187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a 3D co-culture model to investigate the role of primary fibroblasts in ductal carcinoma in situ of the breast.
    Sourouni M; Opitz C; Radke I; Kiesel L; Tio J; Götte M; von Wahlde MK
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1771. PubMed ID: 36534078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma.
    Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Witkiewicz W; Dziegiel P
    Oncol Rep; 2016 Nov; 36(5):2745-2754. PubMed ID: 27633896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
    Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
    Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS).
    He F; Springer NL; Whitman MA; Pathi SP; Lee Y; Mohanan S; Marcott S; Chiou AE; Blank BS; Iyengar N; Morris PG; Jochelson M; Hudis CA; Shah P; Kunitake JAMR; Estroff LA; Lammerding J; Fischbach C
    Biomaterials; 2019 Dec; 224():119489. PubMed ID: 31546097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
    Brummer G; Acevedo DS; Hu Q; Portsche M; Fang WB; Yao M; Zinda B; Myers M; Alvarez N; Fields P; Hong Y; Behbod F; Cheng N
    Mol Cancer Res; 2018 Feb; 16(2):296-308. PubMed ID: 29133591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.
    Van Bockstal M; Lambein K; Gevaert O; De Wever O; Praet M; Cocquyt V; Van den Broecke R; Braems G; Denys H; Libbrecht L
    Histopathology; 2013 Oct; 63(4):520-33. PubMed ID: 23889174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
    Mardekian SK; Bombonati A; Palazzo JP
    Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.